News
Alnylam bets on Tenaya RNAi tech, and other licensing news
This week's round-up of pharma licensing deals features alliances involving Tenaya Therapeutics, Sino Bio, Antengene, and A2A Pharma.
News
PepGen slumps as FDA places hold on lead drug
Shares in PepGen fell sharply after the FDA placed a partial clinical hold on its lead drug for rare neuromuscular disease DM1.
News
Can GLP-1 drugs help tackle addiction?
New research has lent weight to the intriguing idea that GLP-1 agonists may help people with substance use disorders break their addiction.
News
Welsh firm Antiverse raises funds for AI antibody platform
Cardiff's Antiverse has raised $9.3m to develop its AI-based design platform for antibodies against hard-to-reach targets like GPCRs and ion channels.
News
Five projects share £100m UK-US Cancer Grand Challenges fund
Five scientific teams will receive up to £20m each in a new round of funding under the UK and US Cancer Grand Challenges initiative.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
